相关实验视频
Updated: Mar 6, 2026

09:40
Magnetic Adjustment of Afterload in Engineered Heart Tissues
Published on: May 5, 2020
6.3K
细胞葡萄糖吸收的暂时升高加剧了压力过载引起的心脏缩和功能障碍
Sayan Bakshi1,2, Samuel F Chang1,3, Luke A Potter1
1Department of Pathology, Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Epigenetics
|March 4, 2026
概括
之前的高血糖,称为血糖记忆,在第二次压力后加剧了心脏问题. 像DNA甲基化这样的表观遗传变化可能会驱动这些持久的心血管效应,提供潜在的治疗点.
科学领域:
- 心血管科学 心血管科学
- 代谢性疾病研究研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 以前的高血糖症可能会导致长期心血管损伤,称为"血糖记忆".
- 人们假设表观遗传修饰,特别是DNA甲基化,是这种现象的媒介.
- 了解血糖记忆对于预防心脏病进展至关重要.
研究的目的:
- 调查之前高葡萄糖暴露是否会在压力过载下加剧心血管效应.
- 为了识别与心肌细胞中的葡萄糖记忆相关的基因表达和DNA甲基化特征.
- 探索与高血糖相关的心力衰竭易感性的潜在治疗点.
主要方法:
- 使用可诱导,心肌细胞特异性葡萄糖转运体4 (GLUT4) 过度表达的小鼠.
- 诱导高葡萄糖输送,然后恢复到基底水平,然后对小鼠进行横向大动脉收缩 (TAC) 或假手术.
- 评估心脏功能,重塑,基因表达 (RNA测序) 和DNA甲基化 (双硫酸盐测序).
主要成果:
- 在高葡萄糖暴露的小鼠中,TAC加剧了心脏缩和功能障碍.
- 即使葡萄糖水平正常化后,也观察到持续的分子变化,包括改变基因表达和DNA甲基化.
- 丰富的途径表明了基因表达,DNA甲基化和不良心脏事件之间的联系,支持了葡萄糖记忆概念.
结论:
- 血糖记忆会加剧心脏结构和功能衰退,在二次压力下模仿心脏衰竭.
- 确定了转录组和DNA甲基组的变化,这些变化可能作为糖质记忆的分子签名.
- 这些发现表明,由于先前的高血糖症导致的心力衰竭的潜在治疗点.
相关概念视频
Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Glucose Homeostasis: Regulation of Blood Glucose
4.8K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
586
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
586
Pathophysiology of Heart Failure
4.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Heart Failure Drugs: Inotropic Agents
1.7K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K

